Since the 4 kscore test is recommended by the NCCN , there shall be many more Urologists doing this test . They do not want to loose patients to those who offer to do the test . We will know more tomorrow .
I used to invest in many of Frost's stock such as OPK , COCP , RXII , PPRTF , PGLC , CDXC , etc .. and I lost money on most of these stocks except OPK . I see a few differences between OPK and other stocks :
1) In the other stocks Dr Frost is only an investor , he is not running these companies
2) He invested only a small percentage of his asset in these " other companies "
3) He runs OPK and has about 3 billions dollars invested in OPK
To me , OPK has the lowest risk and still has a very bright future .
I do not think Dr. Frost want to sell OPK , at least not yet . He wants to make it a large pharma and leave behind a legacy
China has over 1 billions inhabitants .
plenty of revenues for Tesaro and Opko
At the age of 78 , OPK is probably Dr. Frost last project . He will build it into a large company and most likely will not sell it . When he stop working , it is up to the new management to sell it or not .
I think he will continue to work for the next few years though.
When you google " average income per capita in China , you see about $ 8000 in 2015 going to about $12,000 in 2020 . But is not just China , how about Japan and south America ? So I think $15 billion by 2020 is reasonable revenue
I think even 2.5 million tests is a conservative number . China has over one billion inhabitants and with their improving living standard , more and more people can afford 4 k score test . I about 5 years there is probably 5 millions test / year .
The revenues from 4 k score tests together with Rayaldee will be in the 15 billions dollars range by 2020 . OPK probably will reach $ 300 - $ 500 per share in 5 years .
Where else can you invest relatively safe and get this kind of return ?
As I mentioned on this board before , OPK is a gift from the Lord God , take it .